摘要
交感神经系统是下泌尿生殖道生理功能的神经系统调节系统的组成部分。我们对这种同情系统的作用的认识S由于泌尿生殖系统中β3-肾上腺素受体(β3-Ars)的特性而在过去十年中取得了进展.本文主要从药理学和分子学方面对福的支持作用进行了综述。β3-AR在不同种属男性泌尿生殖组织中的作用。2010至2016年间,我们在两种不同的数据库中进行了电子搜索,其中包括:MEDLINE(PubMed)和EMBASE。β3-AGON基于现有证据,专家在治疗膀胱过度活动(OAB)方面可能是抗uscarinics的一种很有前途的选择。尽管最近的研究已经评估了β3-ars i的参与程度。在下泌尿生殖道各组织的生理调控方面,主要是膀胱、阴茎、尿道、输尿管等,在管道方面鲜有创新。在β3中-甲硝唑是一种独特的药物,用于治疗OAB患者。许多被归类为β3激动剂的药物仍在研究中,用于治疗下尿路OAB。症状,输尿管结石,良性前列腺增生,前列腺癌和勃起功能障碍。本文综述了β3-AR作为新的治疗靶点的潜在作用。与男性泌尿生殖道功能相关的临床前和临床研究。展望未来,对β3潜在的好处,从实验研究和临床AR激动剂ONS可能提供一个有吸引力的治疗方案。
关键词: β3-肾上腺素受体,药物作用,男性泌尿生殖系统,米来盖,排尿,膀胱过度活动.
Current Drug Targets
Title:β3-Adrenoceptor Control of Lower Genitourinary Tract Organs and Function in Male: An Overview
Volume: 19 Issue: 6
关键词: β3-肾上腺素受体,药物作用,男性泌尿生殖系统,米来盖,排尿,膀胱过度活动.
摘要: The sympathetic nervous system is one component of the nervous regulatory system of the physiological function of the lower genitourinary tract. Our knowledge on the role of this sympathetic system has advanced during the last decade due to the characterization of β3-adrenoceptors (β3-ARs) in the urogenital system. This review focuses on the pharmacological and molecular evidence supporting the functional roles of β3-AR in male genitourinary tissues of various species.
An electronic search in two different databases was performed including MEDLINE (PubMed) and EMBASE from 2010 to 2016. β3-agonists may be a promising alternative to antimuscarinics in the treatment of overactive bladder (OAB) based on available evidence.
Although more recent studies have evaluated the involvement of β3-ARs in the physiological control and regulation of various tissues of the lower genitourinary tract mainly urinary bladder, penis, urethra, ureter, there are few innovations in the pipe-line. Among the β3-agonists, mirabegron is a unique drug licensed for the treatment of patients with OAB. Many drugs classified as β3-agonists are still under investigations for the treatment of OAB, lower urinary tract symptoms, ureteral stones, benign prostate hyperplasia, prostate cancer and erectile dysfunction. This review discusses the potential roles of β3-AR as new therapeutic targets by evaluating the results of preclinical and clinical studies related to male lower genitourinary tract function. Looking into the future, the potential benefits of β3- AR agonists from experimental and clinical investigations may provide an attractive therapeutic option.
Export Options
About this article
Cite this article as:
β3-Adrenoceptor Control of Lower Genitourinary Tract Organs and Function in Male: An Overview, Current Drug Targets 2018; 19 (6) . https://dx.doi.org/10.2174/1389450118666170120165554
DOI https://dx.doi.org/10.2174/1389450118666170120165554 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets
Current Signal Transduction Therapy Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis
Current Drug Targets Serotonergic System and Its Role in Epilepsy and Neuropathic Pain Treatment: A Review Based on Receptor Ligands
Current Pharmaceutical Design Back to the Future: COX-2 Inhibitors for Chemoprevention and Cancer Therapy
Mini-Reviews in Medicinal Chemistry Microsatellite Instability (MSI) as Genomic Marker in Endometrial Cancer: Toward Scientific Evidences
Mini-Reviews in Medicinal Chemistry Endometriosis Management: Workflow on Genomics and Proteomics and Future Biomolecular Pharmacotherapy
Current Medicinal Chemistry Implication of Heat Shock Protein 90 (HSP90) in Tumor Angiogenesis: A Molecular Target for Anti-Angiogenic Therapy?
Current Cancer Drug Targets Depot Based Drug Delivery System for the Management of Depression
Current Drug Delivery Recent Patents of microRNAs as Biomarkers for Breast, Leukemia, Prostate and Cervical Cancers
Recent Patents on Biomarkers Clinical Combinatorial Treatments Based on Cancer Vaccines: Combination with Checkpoint Inhibitors and Beyond
Current Drug Targets Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Recent Patents on Biotechnology Propargyl 4-[18F]fluorobenzoate: A Putatively More Stable Prosthetic Group for the Fluorine-18 Labeling of Biomolecules via Click Chemistry
Current Radiopharmaceuticals Noxa: Role in Cancer Pathogenesis and Treatment
Current Cancer Drug Targets The Type II Transmembrane Serine Protease, Matriptase-2: Possible Links to Cancer?
Anti-Cancer Agents in Medicinal Chemistry Current Status on Natural Products with Antitumor Activity from Brazilian Marine Sponges
Current Pharmaceutical Biotechnology The Drug Targeting and Delivery Approach Applied to Pt-Antitumour Complexes. A Coordination Point of View
Current Medicinal Chemistry Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
Recent Patents on Cardiovascular Drug Discovery In Silico Molecular Docking, Synthesis of 4-(4-benzoylaminophenoxy) Phenol Derivatives as Androgen Receptor Antagonists
Combinatorial Chemistry & High Throughput Screening Targeting Autophagic Pathways by Plant Natural Compounds in Cancer Treatment
Current Drug Targets Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors
Current Enzyme Inhibition